RNA药物-话题@MedSci

#RNA药物#

12篇内容 | 692人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1759065, encodeId=369b1e590657d, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, objectType=article, longId=729775, objectId=6f41e29775b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f41e29775b5, replyNumber=0, likeNumber=52, createdTime=2022-10-11, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f41e29775b5, moduleTitle=FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f41e29775b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759063, encodeId=9b021e5906335, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=英博点评 | mRNA药物：不止于新冠, objectType=article, longId=213429, objectId=ca4e21342930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca4e21342930, replyNumber=0, likeNumber=35, createdTime=2021-08-18, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca4e21342930, moduleTitle=英博点评 | mRNA药物：不止于新冠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca4e21342930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759064, encodeId=0b801e59064cb, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=PNAS：许巧兵团队开发肺靶向LNP，实现mRNA药物安全高效和特异性递送, objectType=article, longId=723644, objectId=14bde2364494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14bde2364494, replyNumber=0, likeNumber=38, createdTime=2022-08-25, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14bde2364494, moduleTitle=PNAS：许巧兵团队开发肺靶向LNP，实现mRNA药物安全高效和特异性递送, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14bde2364494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759062, encodeId=7c871e590629e, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=美国FDA延迟批准诺华的siRNA药物inclisiran, objectType=article, longId=204702, objectId=1eb3204e028a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eb3204e028a, replyNumber=0, likeNumber=46, createdTime=2021-10-02, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eb3204e028a, moduleTitle=美国FDA延迟批准诺华的siRNA药物inclisiran, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eb3204e028a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759060, encodeId=75181e5906067, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验, objectType=article, longId=188935, objectId=30b2188935aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30b2188935aa, replyNumber=0, likeNumber=51, createdTime=2020-12-12, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30b2188935aa, moduleTitle=首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30b2188935aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759059, encodeId=8e931e59059fc, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市, objectType=article, longId=185939, objectId=005818593917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005818593917, replyNumber=0, likeNumber=33, createdTime=2020-02-22, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005818593917, moduleTitle=诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005818593917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759061, encodeId=a72e1e5906165, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=Nat COmmun：干扰RNA可助RNA药物逃出子宫内膜进入胞质溶胶！, objectType=article, longId=192736, objectId=b3dd192e36f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3dd192e36f2, replyNumber=0, likeNumber=31, createdTime=2020-10-09, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3dd192e36f2, moduleTitle=Nat COmmun：干扰RNA可助RNA药物逃出子宫内膜进入胞质溶胶！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3dd192e36f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759058, encodeId=27df1e590581a, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=Twentyeight-Seven为非编码RNA药物再筹集1500万美元, objectType=article, longId=166063, objectId=d20216606338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d20216606338, replyNumber=0, likeNumber=41, createdTime=2019-07-16, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d20216606338, moduleTitle=Twentyeight-Seven为非编码RNA药物再筹集1500万美元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d20216606338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759056, encodeId=17271e5905669, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=美药管局批准**小干扰RNA药物, objectType=article, longId=146546, objectId=bcb314654687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcb314654687, replyNumber=0, likeNumber=44, createdTime=2018-10-19, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcb314654687, moduleTitle=美药管局批准**小干扰RNA药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcb314654687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759057, encodeId=74b51e59057fd, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=ACS Cent Sci：中国研究：绿茶中的抗氧化剂可帮助RNA药物进入细胞, objectType=article, longId=150152, objectId=3a49150152a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a49150152a4, replyNumber=0, likeNumber=36, createdTime=2019-02-04, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a49150152a4, moduleTitle=ACS Cent Sci：中国研究：绿茶中的抗氧化剂可帮助RNA药物进入细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a49150152a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759054, encodeId=16b61e5905477, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=Moderna再获4亿5千万风投剑指mRNA药物研发, objectType=article, longId=45125, objectId=fd874512592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd874512592, replyNumber=0, likeNumber=33, createdTime=2015-03-30, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd874512592, moduleTitle=Moderna再获4亿5千万风投剑指mRNA药物研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd874512592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1759055, encodeId=d9391e590551e, content=<a href='/topic/show?id=6a55155e4f2' target=_blank style='color:#2F92EE;'>#RNA药物#</a>, objectTitle=Arrowhead治疗乙肝RNA药物ARC-520临床二期研究再遇阻碍, objectType=article, longId=45527, objectId=f1504552e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1504552e2a, replyNumber=0, likeNumber=29, createdTime=2015-10-24, rootId=0, userName=124987c6m48暂无昵称, userId=36fc37396978, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1504552e2a, moduleTitle=Arrowhead治疗乙肝RNA药物ARC-520临床二期研究再遇阻碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1504552e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RNA药物

2020-05-29

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

FDA批准vutrisiran治疗成人遗传性转甲状腺素蛋白淀粉样变性伴多发性神经病（hATTR-PN），这是第5款siRNA药物

2022-10-11

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

英博点评 | mRNA药物：不止于新冠

2021-08-18

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

PNAS：许巧兵团队开发肺靶向LNP，实现mRNA药物安全高效和特异性递送

2022-08-25

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

美国FDA延迟批准诺华的siRNA药物inclisiran

2021-10-02

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

首批新冠肺炎人体疫苗来了！全球领先mRNA药物研发公司研制，已开启安全性临床试验

2020-12-12

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

诺华97亿收购的PCSK9的siRNA药物inclisiran，预计将于2020年批准上市

2020-02-22

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

Nat COmmun：干扰RNA可助RNA药物逃出子宫内膜进入胞质溶胶！

2020-10-09

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

Twentyeight-Seven为非编码RNA药物再筹集1500万美元

2019-07-16

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

美药管局批准**小干扰RNA药物

2018-10-19

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

ACS Cent Sci：中国研究：绿茶中的抗氧化剂可帮助RNA药物进入细胞

2019-02-04

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

Moderna再获4亿5千万风投剑指mRNA药物研发

2015-03-30

124987c6m48暂无昵称 (审核中...)

前往app查看评论内容

#RNA药物#

Arrowhead治疗乙肝RNA药物ARC-520临床二期研究再遇阻碍

2015-10-24

科室
- - 订阅+
  - 更多科室
工具
服务